Abnormalities, Radiation-Induced: Clinical Trials

9 trials for Abnormalities, Radiation-Induced, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Not yet recruiting 1
Not applicable1Recruiting 1
Phase 31Completed 1

Follow Abnormalities, Radiation-Induced: new trials by email Literature Review of Abnormalities, Radiation-Induced trials Research Report on Abnormalities, Radiation-Induced

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment
Chronic Pelvic Pain Syndrome (CPPS), Radiation-Induced Disorder
RecruitingBernardino Clavo, MD, PhD402025-02-102026-09-25
Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy
Memantine Oral Tablet, Pioglitazone 15mg, Hippocampal avoidance whole-brain radiotherapy (HA-WBRT) - Radiation Disease, Cognitive Impairment
Phase 2Not yet recruitingAffiliated Cancer Hospital & Institute of Guangzhou Medical University672024-09-102024-09-19
Pelvic Radiation Disease in Childhood Cancer Survivors
Radiation Disease
UnknownRoyal Marsden NHS Foundation Trust3002023-10-012023-11-08
Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer
Single-photon-emission CT scan - Lung Cancer, Radiation-Induced Disorder
Not applicableRecruitingUniversity of Aarhus902021-12-012026-02-24
Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy
Educational Intervention, Gabapentin, Pain Therapy - Malignant Head and Neck Neoplasm, Mucositis
Phase 3CompletedVanderbilt-Ingram Cancer Center792015-07-012021-02-18
Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiotherapy of Head and Neck Cancer Patients
Abnormalities, Radiation-Induced
CompletedUniversity Health Network, Toronto202012-06-012021-04-05
Radiation Induced Atherosclerosis in Breast Cancer Patients
carotid intima-media thickening ultrasound - Abnormalities, Radiation-Induced, Atherosclerosis
UnknownHadassah Medical Organization3502006-10-012007-05-16
Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients
Abnormalities, Radiation-Induced
TerminatedState University of New York - Upstate Medical University382006-08-012021-10-22
Evaluation of the Unstimulated Whole Saliva Flow During and After Radiotherapy, With the Use HcT20
Mouthrinse with HcT20 - Abnormalities, Radiation-Induced
Phase 2CompletedUPECLIN HC FM Botucatu Unesp312005-06-012009-04-01

Narrower conditions

Breast Neoplasms (2)  ·  Atherosclerosis (1)  ·  Carotid Artery Diseases (1)  ·  Cognitive Dysfunction (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Mucositis (1)  ·  Radiation Pneumonitis (1)  ·  Respiratory Insufficiency (1)

Broader conditions

Congenital Abnormalities (9)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Radiation Injuries (9)  ·  Wounds and Injuries (9)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Breast Diseases (2)  ·  Mouth Diseases (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Stomatognathic Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)

Interventions

Analgesia (1)  ·  Early Intervention, Educational (1)  ·  Educational Status (1)  ·  Fentanyl (1)  ·  Gabapentin (1)  ·  Ibuprofen (1)  ·  Memantine (1)  ·  Methods (1)  ·  Pain Management (1)  ·  Pioglitazone (1)  ·  Tomography, Emission-Computed, Single-Photon (1)  ·  acetaminophen, hydrocodone drug combination (1)  ·  cyclohexaneacetic acid (1)  ·  oxycodone-acetaminophen (1)

Sponsors

Affiliated Cancer Hospital & Institute of Guangzhou Medical University (1)  ·  Bernardino Clavo, MD, PhD (1)  ·  Hadassah Medical Organization (1)  ·  Royal Marsden NHS Foundation Trust (1)  ·  State University of New York - Upstate Medical University (1)  ·  UPECLIN HC FM Botucatu Unesp (1)  ·  University Health Network, Toronto (1)  ·  University of Aarhus (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United States (2)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  Israel (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Alex I Vitkin, PhD (1)  ·  Amichay Meirovitz, MD (1)  ·  Bernardino Clavo, MD, PhD (1)  ·  Derek Smith, DDS,PhD (1)  ·  Henry C Mandeville, MBChB/MDRes (1)  ·  Mario Federico, MD, PhD (1)  ·  Peter J Hahn, PhD (1)  ·  Sara Cazorla-Rivero, BSc, PhD (1)

Results publications

PMID 23843086, PMID 34418994, PMID 8324987

NIH funding

P30CA068485 (1)